Excellent EAPH news for sure. Glad to see Easton is retaining Auditors to become a fully reporting company. This is one of the next steps for Easton to upgrade market status. WOW!
Marketwired MarketwiredApril 20, 2017
TORONTO, ON--(Marketwired - Apr 20, 2017) - Easton Pharmaceuticals, Inc. ( OTC PINK : EAPH )
The completion of the iBliss acquisition and its sales has resulted in Easton looking to retain auditors for its intent on filing a Form 10 or S1 registration statement towards becoming a fully reporting issuer with the Securities and Exchange Commission.
Evan Karras, CEO of Easton, stated, "We are excited to have completed this strategic acquisition of iBliss and we look forward to working with the iBliss management team to increase our local distribution, expand our international sales and launch innovative consumer health products. Easton has some very exciting plans and this is expected to be the first of many to follow."
Easton has retained the services of new social media and SEO consultants who will assist with a new website design, branding, SEO and Investor Relations.
News 
Market Data 
Discover 
